Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,603 | -3,379 | -1,617 | -14,144 | -4,597 |
| Depreciation Amortization | 78 | 52 | 26 | 101 | 90 |
| Accounts receivable | 57 | -57 | 91 | -123 | 76 |
| Other Working Capital | -515 | -823 | -602 | 607 | -264 |
| Other Operating Activity | 153 | 160 | -31 | 8,060 | 392 |
| Operating Cash Flow | $-5,830 | $-4,048 | $-2,133 | $-5,500 | $-4,302 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -4 | -4 | -8 | -6 |
| Purchase Of Investment | -436 | -275 | -70 | -494 | N/A |
| Sale Of Investment | 455 | 270 | 65 | 7,856 | 6,050 |
| Investing Cash Flow | $15 | $-9 | $-9 | $7,355 | $6,044 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 8,907 | N/A |
| Common Stock Issued | N/A | N/A | 97 | N/A | N/A |
| Other Financing Activity | 97 | 97 | 0 | 0 | 0 |
| Financing Cash Flow | $97 | $97 | $97 | $8,907 | $N/A |
| Beginning Cash Position | 12,367 | 12,367 | 12,367 | 1,605 | 1,605 |
| End Cash Position | 6,649 | 8,407 | 10,322 | 12,367 | 3,347 |
| Net Cash Flow | $-5,718 | $-3,960 | $-2,045 | $10,763 | $1,742 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,830 | -4,048 | -2,133 | -5,500 | -4,302 |
| Capital Expenditure | -4 | -4 | -4 | -8 | -6 |
| Free Cash Flow | -5,834 | -4,051 | -2,136 | -5,507 | -4,308 |